Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy

• Published in: The Eurasian journal of medicine 2019-02, Vol.51 (1), p.27-30
• Main Authors: Ayas, Zeynep Ozozen, Kotan, Dilcan, Akdogan, Mehmet, Gunel, Mustafa Ercan
• Format: Article
• Language: English
• Subjects: Biomarkers; Collagen; EDTA; Enzymes; Epilepsy; Inflammation; Medical research; Medical schools; Operating systems (Software); Original; Oxidative stress; Proline; Seizures (Medicine)
• ISSN: 1308-8734; 1308-8742
• DOI: 10.5152/eurasianjmed.2018.18183

Oxidative stress (OS) and inflammation are considered responsible for the pathogenesis of epilepsy. Prolidase has an extremely important role in proline recycling for collagen synthesis. Higher than normal proline levels have been shown to increase OS. Furthermore, prolidase activity is associated with inflammation during fibrotic process. No study has yet investigated the relationship between epilepsy and prolidase enzyme activity (PEA). In this study, we aimed to contribute to the existing literature by assessing postictal PEA levels, which are correlated with inflammation and OS, to determine whether PEA levels may be used as a biomarker for epilepsy. This study included patients with epilepsy who presented to the emergency department within first 6 h of a seizure. The epileptic group included 27 patients (16 males, 11 females) and the control group included 31 healthy individuals (11 males, 20 females). The mean age of the epilepsy (n=27) and healthy control group (n=31) was 43.1±20.2 and 51.9±21 years, respectively. Serum PEA levels were 1171.90±343.3 in the epileptic group and 1137.1±295.6 in the control group. There were no significant differences between two groups (p>0.05). Our study results suggest that although PEA is an enzyme associated with OS and inflammation, it is still not an ideal biomarker for epileptic patients. This study is important because it investigated PEA in patients with idiopathic epilepsy for the first time.